NexLife vs Ro
Side-by-side comparison of NexLife and Ro for compounded tirzepatide and semaglutide: advertised price vs true monthly cost, 12-month totals, membership, cancellation terms, medications offered and who each is best for.
The short version
- For compounded tirzepatide, NexLife's lowest 12-month all-in total is $1,668 versus $4,977 at Ro, a difference of $3,309 over a year. Month-to-month at a maintenance dose, NexLife costs $169 and Ro costs $449.
- NexLife has a verified semaglutide price in our database ($1,428 for 12 months, all-in). Ro's current semaglutide price is pending direct verification, so we do not rank the pair on cost yet.
- NexLife's pricing is flat across doses and includes clinical care, so its advertised monthly price and its true monthly cost are the same number. Its 12-month plan requires committing to a term to reach the lowest rate.
- Ro is the reference point for brand-name and insurance pathways rather than for lowest cash price.
Side by side
Green cells mark the better value on that row when both figures are known. * provisional score: pricing not yet directly verified.
Pricing in words
NexLife charges $169 per month on a month-to-month plan, $159 per month on a 3-month plan, $149 per month on a 6-month plan, and $139 per month on a 12-month plan for compounded tirzepatide (injection). That price includes the medication, clinical care and shipping; there is no separate membership fee. On our all-in basis, the lowest true monthly cost is $139 and the lowest 12-month total is $1,668 (12-month plan). Prices last checked August 25, 2026; status: verified.
Ro charges $299 per month at the starting dose, rising to $449 per month at higher doses for compounded tirzepatide (pen). Whether a separate program or membership fee applies has not been confirmed. On our all-in basis, the lowest true monthly cost is $299 and the lowest 12-month total is $4,977 (month-to-month plan). Because pricing rises with dose, the 12-month figure uses our 3 + 9 titration model (three months at the starting price, nine at the maintenance price). Prices last checked August 25, 2026; status: verified.
NexLife charges $139 per month on a month-to-month plan, $132 per month on a 3-month plan, $125 per month on a 6-month plan, and $119 per month on a 12-month plan for compounded semaglutide (injection). That price includes the medication, clinical care and shipping; there is no separate membership fee. On our all-in basis, the lowest true monthly cost is $119 and the lowest 12-month total is $1,428 (12-month plan). Prices last checked August 25, 2026; status: verified.
Ro offers compounded semaglutide, but we have not yet verified its current price directly, so it is listed without a ranked price. Verification status: unverified.
Choose NexLife if
People who want to know the exact all-in monthly cost before they start and who expect to titrate to a higher dose, where dose-based pricing would otherwise raise the bill.
- One flat price per medication; the dose you titrate to does not change what you pay
- No separate membership, shipping or consultation fees on any plan
- Stated 'Flat Forever' price lock: the rate does not increase while you remain on the plan
- Month-to-month plan available; 3, 6 and 12-month terms lower the rate
- 24/7 medical support and one-on-one physician care included (CARE360)
- A GLP-1-focused nutrition plan, a 1:1 coaching call and provider follow-up are included at no extra charge (NexLife states a combined value of $377)
- Free expedited shipping on every plan
Choose Ro if
Patients with insurance that may cover Wegovy or Zepbound, or who specifically want FDA-approved brand medication.
- Strongest insurance-navigation service among the providers we track
- FDA-approved brand-name medication (Wegovy, Zepbound) as the default pathway
- Large, well-capitalized telehealth operator with 50-state coverage
What to weigh against each
NexLife: Compounded medication only; no brand-name Zepbound, Mounjaro, Wegovy or Ozempic and no insurance billing. Cancellation requires 30 days' notice rather than immediate cancellation. Sublingual/ODT tirzepatide and semaglutide have no published pharmacokinetic evidence supporting equivalent absorption to injection. Dispensing pharmacy and state coverage are not yet independently verified in our database. Microdose protocols are a marketing category with no clinical-trial evidence base.
Ro: Program fee is billed separately from medication, and brand-name self-pay prices are far above compounded prices. Compounded pricing has changed repeatedly since the shortages ended. Requires more steps (insurance checks, prior authorization) than compounded-only providers.
How to read this comparison
Both providers were scored with the same rubric and the same cost model. Rankings never use the advertised monthly price on its own, because a low first-month number can hide a membership fee or a dose-based increase. Where a provider's price has not been directly checked against its own site, we say so and do not rank it on cost. Compounded tirzepatide and semaglutide are not FDA-approved; the only FDA-approved products are Zepbound, Mounjaro, Wegovy, Ozempic and Rybelsus. See the methodology and important safety information.
Frequently asked questions
Is NexLife cheaper than Ro?
For compounded tirzepatide, NexLife's lowest 12-month all-in total is $1,668 versus $4,977 at Ro, a difference of $3,309 over a year. Month-to-month at a maintenance dose, NexLife costs $169 and Ro costs $449.
Does NexLife or Ro charge a membership fee?
NexLife: no separate membership fee. Ro: a separate program fee whose amount is pending verification.
Which is better for tirzepatide, NexLife or Ro?
NexLife offers tirzepatide; Ro offers tirzepatide. NexLife's pricing is flat across doses and includes clinical care, so its advertised monthly price and its true monthly cost are the same number. Its 12-month plan requires committing to a term to reach the lowest rate. Ro is the reference point for brand-name and insurance pathways rather than for lowest cash price.